Nanoengineered Surfaces Enhance Drug Loading and Adhesion
Source abstract
Abstract
To circumvent the barriers encountered by macromolecules at the gastrointestinal mucosa, sufficient therapeutic macromolecules must be delivered in close proximity to cells.(1) Previously, we have shown that silicon nanowires penetrate the mucous layer and adhere directly to cells under high shear.(2) In this work, we characterize potential reservoirs and load macromolecules into interstitial space between nanowires. We show significant increases in loading capacity due to nanowires while retaining adhesion of loaded particles under high shear.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, United States
UCSF/UCB Joint Graduate Group in Bioengineering, San Francisco, California 94158, United States
Nanosys, Inc.; Palo Alto, California 94304, United States
References (25)
Show source-provided references
1. Khanvilkar K. · Adv. Drug Delivery Rev. · 2001 · 48 · 17310.1016/S0169-409X(01)00115-6 ↗
2. Fischer K. E. · Nano Lett. · 2009 · 9 · 71610.1021/nl803219f ↗
3. Ponchel G. · Adv. Drug Delivery Rev. · 1998 · 34 · 19110.1016/S0169-409X(98)00040-4 ↗
4. Smart J. D. · Adv. Drug Delivery Rev. · 2005 · 57 · 155610.1016/j.addr.2005.07.001 ↗
5. Cone R. A. · Adv. Drug Delivery Rev. · 2009 · 61 · 7510.1016/j.addr.2008.09.008 ↗
6. Degen L. P. · Gut · 1996 · 39 · 29910.1136/gut.39.2.299 ↗
7. Camilleri M. · Am. J. Physiol.: Gastrointest. Liver Physiol. · 1989 · 257 · G284
8. Lehr C. M. · Int. J. Pharm. · 1991 · 70 · 23510.1016/0378-5173(91)90287-X ↗
9. Foraker A. B. · Pharm. Res. · 2003 · 20 · 11010.1023/A:1022211127890 ↗
10. Tao S. L. · Drug Discovery Today · 2005 · 10 · 90910.1016/S1359-6446(05)03489-6 ↗
11. Eaimtrakarn S. · Int. J. Pharm. · 2003 · 250 · 11110.1016/S0378-5173(02)00534-3 ↗
12. Bies C. · Adv. Drug Delivery Rev. · 2004 · 56 · 42510.1016/j.addr.2003.10.030 ↗
13. Lai S. K. · Adv. Drug Delivery Rev. · 2009 · 61 · 15810.1016/j.addr.2008.11.002 ↗
14. Kumar V. · J. Pharm. Sci. · 2008 · 97 · 490410.1002/jps.21342 ↗
15. Freitas S. · J. Controlled Release · 2005 · 102 · 31310.1016/j.jconrel.2004.10.015 ↗
16. Teeguarden J. G. · Toxicol. Sci. · 2007 · 95 · 30010.1093/toxsci/kfl165 ↗
17. Sanvicens N. · Trends Biotechnol. · 2008 · 26 · 42510.1016/j.tibtech.2008.04.005 ↗
18. Tasciotti E. · Nat. Nanotechnol. · 2008 · 3 · 15110.1038/nnano.2008.34 ↗
19. Fischer K. E. · Biomaterials · 2011
20. Anglin E. J. · Adv. Drug Delivery Rev. · 2008 · 60 · 126610.1016/j.addr.2008.03.017 ↗
21. Salonen J. · J. Controlled Release · 2005 · 108 · 36210.1016/j.jconrel.2005.08.017 ↗
22. Salonen J. · J. Pharm. Sci. · 2008 · 97 · 63210.1002/jps.20999 ↗
23. Gagnon P. · 2000
24. Tao, S. L.Off-wafer fabrication of asymmetric, polymeric gastrointestinal micropatch systems: Characterization of caco-2 monolayer binding and compatibility. PhD Thesis,Boston University,Boston, MA, 2006.
25. Desai T. · 2010